Skip to main content

Masthead

  • Member Login
  • Join Mass Senior Care
  • Contact
  • Search
    Advanced Search

Main navigation

  • About Us
    • Learn More About MSCA
    • Board of Directors
    • Staff Directory
    • Newsroom
      • Mass Senior Care Press Releases
      • Mass Senior Care in the News
  • Education & Events
    • Webinars / Education Programs
    • Education and Seminar Policies and Procedures
    • 2023 Annual Meeting and Trade Show
  • Member Resources
    • E-News Updates
      • Past Newsletters
    • Member Updates
    • Preferred Vendors
    • Coronavirus Information and Resources
    • COVID-19 Vaccine
    • Quality & Wellness Initiatives
      • Fight the Flu Campaign
      • The Massachusetts Healthcare Safety and Quality Consortium
      • Sepsis Smart
      • Care Transitions
      • Culture Change
      • End of Life Care
      • Falls Prevention
      • Reducing Off-Label Use of Antipsychotics
    • Labor and Workforce
    • Regulatory
    • Reimbursement
      • Nursing Facility Census
    • Policy Committees
    • Other Resources
      • MassMAP (LTC Mutual Aid Plan)
      • Activities Professional (MassCAP)
      • AHCA/NCAL Bookstore
  • Advocacy
    • Advocacy Center
    • Legislative Priorities
    • Respect & Protect Nursing Home Caregiver Wages
  • Careers
    • Career Opportunities
    • RCA Training Course
    • Care For The Aging
    • Find a Job
    • Members Post a Job
  • For Consumers
    • Care Options
    • Find A Facility
    • How to Choose a Facility
    • Health Care Planning
    • Our Senior Care
  • Foundation

Admission of Residents on Medication for Opioid Use Disorder (MOUD) to Long-Term Care Facilities

Breadcrumb

  • Home
  • Member Resources
  • E-News Updates
  • Admission of Residents on Medication for Opioid Use Disorder (MOUD) to Long-Term Care Facilities
September 15, 2022

On September 12, 2022 the DPH released updated guidance on Admission of Residents on Medication for Opioid Use Disorder (MOUD) to Long-Term Care Facilities. The memo expands upon previous guidance issued in a Circular Letter in November 2016. The guidance includes additional information on methadone, buprenorphine, extended-release injectable naltrexone and the use and storage of naloxone. Mass Senior Care recommends reviewing this document closely.

Upcoming Education & Events

calendar icon
Oct
12

October 12 at 10:00 am

Advancing Diversity, Equity, and Inclusion: Two Part Webinar Series

Nov
16

November 16 at 9:30 am

2023 Annual Meeting and Trade Show

View Entire Calendar

Find a Facility

Recent News

newspaper icon
October 2, 2023
MEMBER UPDATE
September 29, 2023
MEMBER UPDATE
View All Recent News

Find a Preferred Vendor

msca logo

Footer menu

  • Contact
  • Privacy Policy
  • Terms & Conditions

State Affiliate Of